Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
20.23
0.46 (2.33%)
At close: Aug 15, 2025, 3:45 PM
Enliven Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 316K | 316K | 316K | 440K | 440K | 440K | 440K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 312K | 391K | 396K | 315K | 314K | 309K | 297K | 220K | 245K | 666K | 624K | 649K | 569K | 99K | 99K | 74K | 50K | 25K |
Gross Profit | 4K | -75K | -80K | 125K | 126K | 131K | 143K | -220K | -245K | -666K | -624K | -649K | -569K | -99K | -99K | -74K | -50K | -25K |
Operating Income | -114.24M | -110.26M | -104.55M | -100.39M | -97.57M | -93.1M | -83.53M | -64.06M | -50.74M | -39.63M | -31.89M | -37.02M | -39.75M | -43.9M | -45.5M | -48.66M | -47.49M | -44.63M |
Interest Income | 14M | 14.84M | 14.89M | 14.54M | 14.2M | 13.52M | 11.97M | 9.21M | 6.1M | 2.81M | 1.13M | 519K | 169K | 90K | 164K | 276K | 372K | 434K |
Pretax Income | -100.22M | -94.6M | -88.79M | -84.98M | -82.59M | -79.6M | -71.58M | -61.76M | -45.6M | -40.33M | -40.25M | -45.02M | -54.05M | -55.77M | -51.38M | -48.58M | -47.36M | -44.4M |
Net Income | -100.22M | -94.83M | -89.02M | -85.21M | -82.83M | -79.6M | -71.58M | -20.03M | -9.81M | -1.98M | 4.07M | -36.5M | -39.6M | -43.87M | -45.46M | -48.58M | -47.36M | -44.4M |
Selling & General & Admin | 25.87M | 24.56M | 23.78M | 22.43M | 21.26M | 20.43M | 18.95M | 16.1M | 14.56M | 10.69M | 7.77M | 7.33M | 7.47M | 9.46M | 10.98M | 12.04M | 11.76M | 11.13M |
Research & Development | 88.37M | 85.7M | 80.7M | 77.8M | 76.15M | 72.51M | 64.5M | 46.85M | 35.07M | 27.83M | 23M | 29.69M | 32.26M | 34.39M | 34.45M | 36.55M | 35.68M | 33.48M |
Other Expenses | -80K | -80K | -80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 114.16M | 110.18M | 104.39M | 100.23M | 97.41M | 92.94M | 83.45M | 64.06M | 50.74M | 39.63M | 31.89M | 37.02M | 39.72M | 43.85M | 45.43M | 48.58M | 47.44M | 44.6M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24K | -49K | -74K | -74K | -50K | -25K |
Cost & Expenses | 85.66M | 110.26M | 104.55M | 100.39M | 97.57M | 93.1M | 83.53M | 64.06M | 50.74M | 39.63M | 31.89M | 37.02M | 39.75M | 43.9M | 45.5M | 48.66M | 47.49M | 44.63M |
Income Tax Expense | n/a | 232K | 232K | 232K | 232K | -48.09K | -48.09K | 39.91K | 281.92K | -113K | -99K | -179K | -409K | 42K | 51K | 75K | 134K | 224K |
Shares Outstanding (Basic) | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | 41.13M | 41.03M | 40.96M | 18.52M | 6.57M | 6.57M | 6.57M | 6.57M | 6.57M | 6.22M | 4.43M | 4.39M |
Shares Outstanding (Diluted) | 52.11M | 50.05M | 49.86M | 48.27M | 48.08M | 42.05M | 41.13M | 41.03M | 40.96M | 18.52M | 6.57M | 6.57M | 6.57M | 6.57M | 6.57M | 6.22M | 4.43M | 4.39M |
EPS (Basic) | -2 | -1.92 | -1.89 | -1.9 | -1.93 | -1.93 | -2.19 | 3.18 | 2.99 | 1.66 | 0.23 | -6.85 | -8.34 | -9.57 | -9.67 | -10.12 | -10.79 | -10.19 |
EPS (Diluted) | -2 | -1.92 | -1.89 | -1.9 | -1.93 | -1.93 | -2.19 | 3.18 | 2.99 | 1.66 | 0.23 | -6.85 | -8.34 | -9.57 | -9.67 | -10.12 | -10.79 | -10.19 |
EBITDA | -114.08M | -110.02M | -104.24M | -100.07M | -97.25M | -92.79M | -83.23M | -70.68M | -57.38M | -46.29M | -38.58M | -36.84M | -39.59M | -43.76M | -45.35M | -48.49M | -47.26M | -44.3M |
EBIT | -82.51M | -107.11M | -104.55M | -100.39M | -97.57M | -91.8M | -82.23M | -69.66M | -56.35M | -46.53M | -38.79M | -37.02M | -39.74M | -43.88M | -45.46M | -48.58M | -47.36M | -44.4M |
Depreciation & Amortization | 234K | 312K | 317K | 314K | 312K | 308K | 296K | 283K | 309K | 730K | 688K | 649K | 569K | 99K | 99K | 97K | 98K | 98K |